And a second announcement: closure of $95M series C raise for AjaxTherapeutics to support AJ1-11095 clinical development and other studies. Excited that investing partners also see the potential for this approach to transform MPN therapy! 🙂 Ross Levine #MPNsm

“I apologize for the busy slide” - ⁦The FAA ✈️⁩ & ⁦americanair⁩ taking after academic conference speakers #MedTwitter

A generation of biochem students wrestled with and learned from Stryer’s classic Biochemistry textbook. May he rest in peace.

#MedTwitter
#Biochemistry

Did anyone else find that when they registered for the ASCO annual meeting, their organization/institution name was pre-populated by the lengthy name of a small business development consultancy in Istanbul, Turkey? Just me? Curious web glitch. 🤔

Nice perspective by Andrea Valdez on history & value of postage stamps just published The Atlantic.

Preview of next 3 #MedTwitter philatelic vignettes in Mayo Clinic Proceedings: Betty Ford, Wilfred Grenfell of Newfoundland & Labrador, and a 600+ y/o pharmacy.

theatlantic.com/technology/arc…

There was a neurology attending I rotated with as an intern in '97 who would check off *all* the boxes on lab slips because, you know, every once and a while he would 'find something'. I think that guy almost single-handedly ushered in the era of prior authorizations.

MTHFR?! 🤦‍♂️

Not often that we see cyclophosphamide and haploidentical hematopoietic cell transplantation as the focus of a feature article in a mainstream magazine. Nice write-up in The Atlantic: CIBMTR ASH theatlantic.com/health/archive…